Insider Cluster (2 insiders) ·Filed Mar 6, 2026
Insider cluster: 2 insiders, $705K total
Actionable Insight • Neutral
Monitor for additional insider selling in the next quarter; current activity appears to be routine portfolio management or tax-related, not a signal of fundamental deterioration.
Final — all horizons settled through T+60d
SUPN ▼ -16.91% at T+60d
NEUTRAL call ✗ call lost -16.91% · α vs SPY -29.69% · entry $53.87 → $44.76
T+1d
+0.56%
call +0.56% · α -0.29%
$54.17
settled 7mo ago
T+5d
-7.35%
call -7.35% · α -5.82%
$49.91
settled 7mo ago
T+20d
-6.18%
call -6.18% · α -4.14%
$50.54
settled 6mo ago
T+60d
-16.91%
call -16.91% · α -29.69%
$44.76
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Multiple insiders at Supernus Pharmaceuticals sold shares in the past week, including SVP William Todd and Director Georges Gemayel, with total open-market sales amounting to $1.5M. Most transactions were tied to option exercises and tax withholdings, which are routine non-cash events.
Key Financial Metrics
Direction
selling
Total Value
$1.5M
Insiders
2
Key Facts
- SVP William Todd sold 8,877 shares in open-market transactions for $483,797.
- Director Georges Gemayel sold 18,787 shares in open-market transactions for $1,002,811.
- Total open-market sales by insiders in the cluster: $1.5M.
- Multiple non-cash transactions occurred: option exercises and tax withholding, totaling $0 in net cash proceeds to insiders.
- All sales occurred at prices between $53 and $55, representing no significant discount to market value.
Financial Impact
$1.5 million in total open-market insider sales over 7 days
insider ownershipmarket sentiment
Risk Factors
- Perception of insider pessimism if selling continues beyond typical option-exercise patterns.
- Concentration of selling among senior executives could attract negative attention if fundamentals weaken.
Market Snapshot
Exchange
Nasdaq
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (9 trades, 7d window) | cluster-SUPN-1773173561465 |
20 reports for SUPN
75% Hit rate best @ T+1▲ +8.46%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 20d ago | DEFM14A | $41.49 $42.78 | ▲ +3.11% | ▲ +3.00% | $42.60 (+2.68%) |
Aug 3, 2026 8w ago | DEFA14A / 425 | $43.25 $46.88 | ▲ +8.39% | ▲ +8.49% | $42.60 (−1.50%) |
Aug 3, 2026 8w ago | 8-K | $43.25 $46.88 | ▲ +8.39% | ▲ +8.49% | $42.60 (−1.50%) |
Aug 3, 2026 8w ago | DEFA14A / 425 | $46.00 $47.07 | ▲ +2.33% | ▲ +0.30% | $42.60 (−7.39%) |
Aug 3, 2026 8w ago | 8-K | $46.00 $47.07 | ▲ +2.33% | ▲ +0.30% | $42.60 (−7.39%) |
Aug 3, 2026 8w ago | 8-K | $46.00 $47.07 | ▲ +2.33% | ▲ +0.30% | $42.60 (−7.39%) |
Aug 3, 2026 8w ago | DEFA14A / 425 / 8-K | $46.00 $47.07 | ▲ +2.33% | ▲ +0.30% | $42.60 (−7.39%) |
Jul 22, 2026 10w ago | 8-K | $47.19 $45.61 | ▼ −3.35% | ▼ −3.82% | $42.60 (−9.73%) |
Jul 22, 2026 10w ago | Press Release | $47.19 $45.61 | ▼ −3.35% | ▼ −3.82% | $42.60 (−9.73%) |
Jul 20, 2026 10w ago | Court Ruling | $47.42 $46.20 | ▼ −2.57% | ▼ −2.15% | $42.60 (−10.16%) |
Showing 10 of 20
US Market Status
Market Open — Closes in 52m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access